Basic Information
| LncRNA/CircRNA Name | X91348 |
| Synonyms | NA |
| Region | NA |
| Ensemble | ENSG00000237517 |
| Refseq | NR_002733 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Hepatocellular Carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | HCC tissues and corresponding adjacent non-cancerous tissues |
| Expression Pattern | down-regulated |
| Function Description | X91348 expression was decreased in patients with HCC compared with healthy controls no matter in tissue or serum samples.The result demonstrated that tumour size, HBsAg and Child-Pugh were vital influencing factors for X91348 expression, which revealed X91348 may be involved in the progress of HCC.X91348 was proved to be closely related to the prognosis of HCC. Taken together, the down-regulation of X91348 could be an independent diagnostic and prognostic indicator for HCC. |
| Pubmed ID | 31349749 |
| Year | 2019 |
| Title | The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma |
External Links
| Links for X91348 | GenBank HGNC NONCODE |
| Links for Hepatocellular Carcinoma | OMIM COSMIC |